http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009291086-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c887ee8afb84f2f4a5220d1c4b085d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2009-05-21^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7237ebb111a470e39058cdfabfc527a1 |
| publicationDate | 2009-11-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2009291086-A1 |
| titleOfInvention | Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia |
| abstract | Modified annexin proteins, including heterodimers and homodimer of various human annexins, are provided for treatment of cerebral thrombosis and global cerebral ischemia. Also provided are phosphatidylserine (PS) binding proteins for treatment of cerebral thrombosis and global cerebral ischemia. The modified annexins and/or PS binding proteins bind PS on cell surfaces, thereby preventing the attachment of leukocytes and platelets to endothelial cells during post-ischemic reperfusion. By maintaining endothelial cell and vascular wall integrity PS binding proteins and/or modified annexin proteins decrease cerebral hemorrhage. Modified annexins and other PS binding proteins also suppress the production of mediators of edema, the extension of cerebral damage during reperfusion and the risk of rethrombosis. Thus, modified annexin proteins and/or other PS binding proteins decrease brain damage following cerebral thrombosis and global cerebral ischemia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103987401-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011069090-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11357823-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2701730-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021205409-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222030-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014121163-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023165624-A1 |
| priorityDate | 2001-02-21^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 902 of 902.